CG
VCYT icon

Caprock Group’s Veracyte VCYT Stock Holding History

Caprock Group’s Portfolio VCYT Stock Details VCYT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$451K Buy
7,682
+1,076
+16% +$45.1K 0.01% 887
2026
Q1 		$213K Sell
6,606
-442
-6% -$16.4K 0.01% 1036
2025
Q4 		$297K Buy
7,048
+185
+3% +$7.46K 0.01% 1005
2025
Q3 		$208K Buy
+6,863
New +$197K 0.01% 1052
2025
Q1 		$205K Buy
6,915
+63
+0.9% +$2.4K 0.01% 1001
2024
Q4 		$271K Sell
6,852
-555
-7% -$21K 0.01% 843
2024
Q3 		$252K Buy
+7,407
New +$208K 0.01% 777

Other funds holding VCYT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Caprock Group's VCYT Position: Q2 2026 in Review

Caprock Group increased its Veracyte (VCYT) stake by 16% in Q2 2026, buying an estimated $45.1K and bringing the position to 7,682 shares worth $451K. The position accounts for 0.01% of the portfolio, ranked #887.

Caprock Group first reported a position in VCYT in Q3 2024 and has held it in 7 quarters since. 371 funds tracked by Wall St. Rank hold VCYT as of Q2 2026.

  • Caprock Group held 7,682 shares of Veracyte worth $451K as of Q2 2026.
  • Caprock Group bought 1,076 Veracyte shares in Q2 2026, an estimated $45.1K.
  • Veracyte made up 0.01% of Caprock Group's portfolio in Q2 2026, its #887 holding.
  • Caprock Group first reported a position in Veracyte in Q3 2024 and has held it in 7 quarters since.
  • 371 funds tracked by Wall St. Rank held Veracyte as of Q2 2026.

Based on Caprock Group's 13F filing for Q2 2026, filed 27 Jul 2026.